1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/11/2024 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | RBC Capital | Ben Hendrix | → $13 | Reiterates | Sector Perform → Sector Perform | Get Alert |
01/18/2024 | EHTH | Buy Now | eHealth | $5.45 | 28.44% | Craig-Hallum | George Sutton | $7 → $7 | Downgrade | Buy → Hold | Get Alert |
08/14/2023 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | RBC Capital | Ben Hendrix | → $13 | Reiterates | Sector Perform → Sector Perform | Get Alert |
08/09/2023 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Citigroup | Daniel Grosslight | $9 → $10 | Maintains | Neutral | Get Alert |
08/09/2023 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Deutsche Bank | George Hill | $5 → $10 | Maintains | Hold | Get Alert |
05/19/2023 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | RBC Capital | Ben Hendrix | → $13 | Reiterates | Sector Perform → Sector Perform | Get Alert |
05/15/2023 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | RBC Capital | Ben Hendrix | → $13 | Reiterates | Sector Perform → Sector Perform | Get Alert |
05/10/2023 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Credit Suisse | Jonathan Yong | → $10 | Reiterates | → Neutral | Get Alert |
04/28/2023 | EHTH | Buy Now | eHealth | $5.45 | 28.44% | Citigroup | Daniel Grosslight | $10 → $7 | Maintains | Neutral | Get Alert |
03/08/2023 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Citigroup | Daniel Grosslight | $4.5 → $10 | Maintains | Neutral | Get Alert |
03/06/2023 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | RBC Capital | Ben Hendrix | $16 → $13 | Maintains | Sector Perform | Get Alert |
03/06/2023 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Credit Suisse | Jonathan Yong | $4 → $10 | Maintains | Neutral | Get Alert |
08/15/2022 | EHTH | Buy Now | eHealth | $5.45 | 83.49% | Credit Suisse | Jonathan Yong | $13 → $10 | Maintains | Neutral | Get Alert |
08/09/2022 | EHTH | Buy Now | eHealth | $5.45 | 46.79% | Truist Securities | Tobey Sommer | $12 → $8 | Maintains | Hold | Get Alert |
08/09/2022 | EHTH | Buy Now | eHealth | $5.45 | 193.58% | RBC Capital | Ben Hendrix | $17 → $16 | Maintains | Sector Perform | Get Alert |
05/04/2022 | EHTH | Buy Now | eHealth | $5.45 | 138.53% | Credit Suisse | Jailendra Singh | $16 → $13 | Maintains | Neutral | Get Alert |
03/21/2022 | EHTH | Buy Now | eHealth | $5.45 | 175.23% | Citigroup | Daniel Grosslight | $37 → $15 | Downgrade | Buy → Neutral | Get Alert |
03/03/2022 | EHTH | Buy Now | eHealth | $5.45 | 193.58% | Credit Suisse | Jailendra Singh | $31 → $16 | Maintains | Neutral | Get Alert |
03/02/2022 | EHTH | Buy Now | eHealth | $5.45 | 175.23% | Truist Securities | Tobey Sommer | → $15 | Downgrade | Buy → Hold | Get Alert |
The latest price target for eHealth (NASDAQ: EHTH) was reported by RBC Capital on March 11, 2024. The analyst firm set a price target for $13.00 expecting EHTH to rise to within 12 months (a possible 138.53% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for eHealth (NASDAQ: EHTH) was provided by RBC Capital, and eHealth reiterated their sector perform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of eHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for eHealth was filed on March 11, 2024 so you should expect the next rating to be made available sometime around March 11, 2025.
While ratings are subjective and will change, the latest eHealth (EHTH) rating was a reiterated with a price target of $0.00 to $13.00. The current price eHealth (EHTH) is trading at is $5.45, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.